BioNTech
BNTX
BioNTech (BNTX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$3.70
- EPS estimate
- −$3.70
- EPS surprise
- +0.00%
- Revenue surprise
- −28.82%
- Revenue
- $120.6M
- Revenue estimate
- $169.4M
- Reported
- Aug 4, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | −$3.70 | −$3.70 | +0.00% | $120.6M | SEC |
| Q1 2026 | May 5, 2026 | −$2.54 | −$2.43 | +4.42% | $136.4M | SEC |
| Q4 2025 | Mar 10, 2026 | −$0.19 | −$1.47 | −673.50% | $1.1B | SEC |
| Q3 2025 | Nov 3, 2025 | −$1.12 | −$0.14 | +87.40% | $1.8B | SEC |
| Q2 2025 | Aug 4, 2025 | −$2.69 | −$1.88 | +29.91% | $307.2M | SEC |
| Q1 2025 | May 5, 2025 | −$2.48 | −$1.87 | +24.47% | $197.8M | SEC |
| Q4 2024 | Mar 10, 2025 | $0.46 | $1.12 | +141.78% | $1.2B | SEC |
| Q3 2024 | Nov 4, 2024 | −$1.74 | $0.90 | +151.79% | $1.4B | SEC |
| Q2 2024 | Aug 5, 2024 | −$2.19 | −$3.60 | −64.22% | $137.9M | SEC |
| Q1 2024 | May 6, 2024 | −$1.34 | −$1.41 | −5.37% | $202.4M | SEC |
| Q4 2023 | Mar 20, 2024 | $2.62 | $2.10 | −20.00% | $1.6B | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.62 | $0.71 | +213.55% | $946.4M | SEC |
| Q2 2023 | Aug 7, 2023 | −$0.91 | −$0.86 | +5.21% | $182.9M | SEC |
| Q1 2023 | May 8, 2023 | $0.29 | $2.22 | +673.34% | $1.4B | SEC |
| Q4 2022 | Mar 27, 2023 | $8.32 | $9.91 | +19.05% | $4.6B | SEC |
| Q3 2022 | Nov 7, 2022 | $3.35 | $6.84 | +104.07% | $3.4B | — |
| Q2 2022 | Aug 8, 2022 | $7.42 | $6.76 | −8.93% | $3.4B | — |
| Q1 2022 | May 9, 2022 | $10.14 | $15.76 | +55.42% | $7.1B | — |
| Q4 2021 | Mar 30, 2022 | $8.46 | $13.84 | +63.65% | $6.3B | — |
| Q3 2021 | Nov 9, 2021 | $12.20 | $14.30 | +17.18% | $7.0B | — |
Quarterly revenue
Frequently asked questions
When did BioNTech (BNTX) last report earnings?
BioNTech last reported on Aug 4, 2026, covering fiscal Q2 2026.
Did BNTX beat earnings estimates?
BioNTech reported EPS of −$3.70 for Q2 2026, in line with the −$3.70 consensus estimate.
How much revenue did BNTX report last quarter?
BioNTech reported $120.6M in revenue for Q2 2026, against a consensus estimate of $169.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.